Delivery Order SPE2DR25D2104-SPE2DR26F3QMP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,047.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through AmerisourceBergen's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,873.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $11,906.66. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $1,864.56. This firm fixed-price delivery order, with an ultimate completion date of October 27, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support under its existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,895.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $7,330.39. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by May 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,893.13 on December 9, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $16,150.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). This competitive contract, executed on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QMPDelivery Order
The Defense Logistics Agency awarded a $11,651.61 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price delivery order, which is not subject to any set-aside designation, represents a competitively awarded contract under the company's existing indefinite delivery vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 5, 2025. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, medical devices, and specialized healthcare commodities. AmerisourceBergen's federal contract portfolio demonstrates its significant role as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with consistent delivery of both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 12/3/25 |